DONQ52
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for DONQ52, covering 2025-01-31 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: Study of DONQ52 in Active Celiac Disease [Phase 2]